Please login to the form below

Not currently logged in
Email:
Password:

non-adherence

This page shows the latest non-adherence news and features for those working in and with pharma, biotech and healthcare.

Behaviour change needs a quantified approach

Behaviour change needs a quantified approach

Non-adherence to treatment currently ranges from 25% to an eye-watering 78%.

Latest news

  • Assisting adherence Assisting adherence

    Helping transplant patients. A particularly interesting case for medication non-adherence exists among transplant patients. ... EFPIA estimates non-adherence causes 200, 000 premature deaths every year in the EU.

  • Things can only get better Things can only get better

    tools to support patients, the incidence of non-adherence remains stuck where it was in the 90s. ... Chris Edmonds, managing director, emotive, thinks this is essential if we're to shift the needle of non-adherence. “

  • Changing behaviours begins at home Changing behaviours begins at home

    For example, research shows that non-adherence to medicines is often related to patients' beliefs about their illness and treatment.

  • Responding to non-adherence Responding to non-adherence

    Non-adherence costs the EU approximately 125bn and nearly 200, 000 lives every year. ... Non-adherence is a global epidemic. Collaborative solutions. The battle to improve adherence is a collective responsibility.

  • The behavioural science of adherence The behavioural science of adherence

    In order to tackle the problem, it's necessary to understand the varying types and causes of non-adherence. ... Interventions should then be tailored accordingly. According to Prof Weinman, there are two types of non-adherence: unintentional

More from news
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • A new era of smart pharma A new era of smart pharma

    According to a systematic review of 39 studies, published in Clinical Psychology in 2002, a mean rate of medication non-adherence in schizophrenia sufferers is 41%, one of the highest of ... Furthermore, given the serious negative effects of

  • Six degrees of participation Six degrees of participation

    As we’ve established, not all patients want to ‘participate’. But by meeting them halfway - and developing tools that speak their language - we can reduce the barriers to non-adherence. ... patients. These are patient-centred, not brand-led,

  • The rise of real-world evidence The rise of real-world evidence

    real world, where comorbidities, non-adherence and other issues controlled for in trials affect outcomes. ... approval. When combined with the rising demand for non-RCT data from payers and providers, the evolution of regulatory attitudes will establish

  • Implementing eHealth innovation Implementing eHealth innovation

    To achieve this high level of adherence, the treatment requires a long-term commitment from patients, caregivers, nurses and physicians. ... In the EU alone, it has been estimated that there are nearly 200, 000 deaths a year due to missed doses and

  • Adding value in emerging markets Adding value in emerging markets

    And it is widely known that non-adherence can lead to poor health outcomes.

More from intelligence
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Why patient education isn’t simple

    At this point, medication adherence is likely to increase, complications reduce, and patient progress enhance. ... This relationship can enable not only patient activation but patient participation in the decision-making process around their treatment

  • How do you solve a problem like non-adherence? Part 2

    In part one of this series, Elisa del Galdo looked at the complex factors around patient non-adherence. ... How do you solve a problem like non-adherence - part 2- Blue Latitude.

  • How do you solve a problem like non-adherence? Part 1

    Typically, complex and long term treatment regimens contribute greatly to non-adherence statistics. ... How do you solve a problem like non-adherence - part 1 - Blue Latitude.

  • Research Partnership

    In this month’ s column we look at the issue of non-adherence, the risk of bias in adherence surveys and how a better understanding of true patient behavior is critical ... In this month’ s column we look at Hepatitis C and examine the differences

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics